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Abstract 
 
Background: Because of the low prevalence of Human T Lymphotropic Virus type I (HTLV-I) in comparison with 
Khorasan Province, considering HTLV-I as an etiology of spastic paraparesia, it may be neglected in evaluation 
of spastic paraparesis in the other regions of Iran. Some reports of spastic paraparetic patients due to HTLV-I 
infection in West Azarbaijan, caused us to reconsider the importance of HTLV-I epidemiology in the other areas 
of the country. 
 
Methods: All spastic paraparetic patients who referred to Motahari and Imam Khomeini educational hospitals of 
Urmia from September 2004 to September 2007 were assessed for HTLV-I infection antibodies. 
 
Results: In our 3 years study, 11 cases were diagnosed as Human T Lymphotropic Virus type I Associated 
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP, 2 males and 9 females).The mean age of patients at the 
time of diagnosis was 45.8 years. Dorsal and cervical MRI of all patients was normal. Serum Enzyme-Linked 
Immuno-Sorbent Assay (ELISA) and Western blot (WB) for anti HTLV-I antibody in all patients was positive. Four 
patients underwent for lumbar puncture in which were normal in respect of cells and biochemistry, but positive for 
anti-HLTLV-I antibodies. 
 
Conclusion: HAM/TSP detection in West Azarbaijan in spite of its long distance from Khorasan Province shows 
the importance of anti-HTLV-I Ab assay in the blood and CSF of every spastic paraparetic patient all over the 
country. 
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Introduction 
 
During the past 25 years, Human T Lymphotropic 
Virus type I (HTLV-I) epidemiology has been studied 
many times getting more advanced day by day. Geo-
graphical distribution of virus in the world was previ-
ously demonstrated. Although several studies showed 
the high prevalence of HTLV-I in Japan southwest, 
however the prevalence of virus in adjacent countries 
like Korea, China, Eastern Russia and Khorasan in 
Iran is low.
1 HTLV-I can induce several diseases such 
as Adult T Cell Leukemia (ATL), Human T Lympho-
tropic Virus type I Associated Myelopathy/Tropical 
Spastic Paraparesis (HAM/TSP), sensori-motor poly-
neuropathy and optic neuritis.
2-4 Many cases of dis-
ease due to transmission are well established and the 
disease is known as a sexual transmitted disease.
5 The 
majority of epidemiologic studies are based on sero-
logic screening for anti HTLV-I anti body (Ab) by 
using blood Enzyme-Linked Immuno-Sorbent Assay 
(ELISA)  and is confirmed by Western Blot (WB) 
test.
6 Polymerase Chain Reaction (PCR) is used to 
confirm HTLV-I typing diagnosis.
7 The presence of 
endemic area in north-east of Iran (especially Mash-
had, Neishaboor and adjacent areas), doubled the im-
portance of HTLV-I epidemiologic studies in Iran. So 
in this area of the country every spastic paraparetic 
patient who referred is evaluated for anti HTLV-I Ab, 
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but many reports indicate the existence of HAM/TSP 
in the other regions of the country such as West 
Azarbaijan and it challenged us to evaluate cumulative 
prevalence of this disease in the West Azarbaijan and 
discover the importance of HTLV-I epidemiology 
around Iran. 
 
 
Materials and Methods 
 
All patients presented with spastic paraparesia and 
referred to Motrahari and Imam Khomeini hospitals 
in Urmia, from September 2004 to September 2007 
were assessed for anti HTLV-I Ab.  
All patients after systemic and neurologic exami-
nations underwent dorsal and cervical Magnetic Res-
onance Imaging (MRI). After ruling out of compres-
sive lesions all patients’ blood were tested for anti 
HTLV-I Ab with ELISA and WB methods. Only four 
patients allowed us to do lumbar puncture for Cere-
bro-spinal Fluid (CSF) analysis (cell, biochemistry 
and anti HTLV-I Ab). The results are presented in 
Table1 and 2. 
 
 
Results 
 
Eleven patients (2 males and 9 women) were diag-
nosed as HAM/TSP. The mean age for diagnosis was 
45.8 years and for beginning of symptoms based on 
history was 36.3 years old. Three patients had a histo-
ry of blood transfusion (all were women). Three pa-
tients were under treatment for primary progressive 
multiple sclerosis. All patients underwent dorsal and 
cervical MRI which were normal.  
Using ELISA and WB methods showed anti-HTLV-
I Ab in all patients. Only four patients underwent lum-
bar puncture in which all were normal for cell and bio-
chemistry but positive for anti-HTLV-I antibodies. 
Discussion 
 
Epidemiologic studies have been done over the past 
25 year's demonestrating worldwide distribution of 
HTLV-I with different prevalence rates. Because of 
wide distribution of HTLV-I infection all over the 
world, doing epidemiological studies in every region 
(even non-endemic areas) is essential. In some non-
endemic areas such as rural West African
8 and South 
American Indians (Mapuches) from Chile,
9 the results 
were interesting. These studies have been done among 
high risk groups and at risk populations such as preg-
nant women.
10 In Iran, these studies showed some en-
demic areas in Khorasan Province. Our findings 
showed that there was a least approximately 10 years 
interval between the appearance of the symptoms and 
the diagnosis of disease, indicating that there has been 
no sufficient notice in finding the virus in the other 
regions of the country such as Azarbaijan Province. 
Finding three cases of HTLV-I positive people, due to 
blood transfusion indicates the importance of screening 
for the virus before any blood transfusion. This fact is 
not supported the need for HTLV-I/II antenatal screen-
ing in some non-endemic areas such as Greece.
11 
A positive blood result for HTLV-I by ELISA in 
all patients indicates the high sensitivity of this test 
and repeatedly, proving the fact that ELISA is the 
best screening test in HTLV-I assay. Normal dorsal 
and cervical MRI in patients who referred to us with 
spastic paraparesia, reinforces the suspicion for viral 
and infectious etiologies such as HTLV-I. The pres-
ence of upper motor neuron signs with less severity in 
upper limbs is an interesting finding in which should 
be considered in HAM/TSP. 
Reporting 11 HAM/TSP patients in West   
Azarbaijan during a three years interval indicates the 
distribution of HTLV-I in Iran that remind us of the 
necessity for evaluation of any patient who refer with 
spastic paraparesia or spastic tetraparesia for HTLV-I. 
Table 1: Presenting symptoms of patients diagnosed as HAM-TSP
Gait disturbance  Urinary disturbance (frequency and 
incontinence) 
Low back  and lower 
limb pain  Paresthesia 
11/11 10/11  7/11  6/11 
 
 
Table 2: Objective findings in patients diagnosed as HAM-TSP.
Spastic 
gait  Babinski sign  Weakness  Hyper-reflexia  Sensory impairment 
(lower limb) 
 
 
11/11 
 
 
11/11 
 
 
11/11 
Upper limb  Lower limb  Pain and  
temperature 
Position and
properioceptive 
6/11 11/11 2/11  7/11 Boostani et al. 
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Regarding the possibility of HTLV-I transmission by 
blood transfusion, assessing the patients with the his-
tory of blood transfusion in past decades should be 
considered. Finally we are emphasizing that 
HAM/TSP should be considered in patients with sub-
jective complains such as urinary incontinence or   
frequency, distal paresthesia, dysesthesia, muscle 
stiffness and gait disturbances. 
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